EN | ES | DE | FR | IT | 日本語 | 한국어 | 中文

Katherine Ann Rubino

mm

Patent Attorney

Caldwell Intellectual Property Law

katie@caldwellip.com

January 18, 2019

Final Decision Reached in Initial Insulin IPR Proceeding

Final Decision Reached in Initial Insulin IPR Proceeding   By: Katie Rubino       On December 12th, 2018 the U.S. Patent and Trademark Appeal Board (PTAB) […]
January 11, 2019

How to Allocate Resources to Intellectual Property as a Start-Up

  How to Allocate Resources to Intellectual Property as a Start-Up   By: Katie Rubino     When a venture is first getting off the ground, there […]
December 10, 2018

Protein Kinase Inhibitors: Inventing New Patent Strategies

A review of new patent strategies developing around protein kinase inhibitors by patent attorney Katie Rubino.
November 18, 2018

Data Tug of War: USMCA Sets to Implement Uniform Data Protection for Biological Pharmaceutical Products

Legal Review: The United States-Mexico-Canada Agreement compared with NAFTA as it relates to IP, with a special focus on how it could affect chemical and biological pharmaceutical products.
November 5, 2018

Federal Circuit Upholds PTAB Findings in Interference over CRISPR Gene Editing Patent Applications

Court Case Review: University of California v. Broad Institute, Inc. #2017-1907 by Patent Attorney Katie Rubino. Case involves CRISPR-Cas9 patents held by Harvard and MIT.